Clinical Trials for Resectable Pancreatic Cancer

Find clinical trials for resectable pancreatic cancer. Discover research opportunities and treatment options in your area.

8 Active Trials Found

Showing 8 trials on this page

Page 1 of 1

Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy

NCT ID: NCT07022015

This clinical trial is studying the risk factors that may lead to a complication called a postoperative pancreatic fistula (POPF) after a surgery known as pancreaticoduodenectomy (PD). This surgery...

Recruiting

Phase: NA Type: interventional Locations: Minya, , Egypt

Comparative Study Between Immediate Surgery Versus Neoadjuvant Chemotherapy for Management of Resectable Pancreatic Cancer

NCT ID: NCT06978322

This clinical trial is studying how effective two different treatment approaches are for patients with resectable pancreatic cancer, which means that the tumor can be surgically removed. The trial ...

Recruiting

Type: observational Locations: Minya, , Egypt

NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)

NCT ID: NCT05529940

The NeoFOL-R Trial is studying the best way to treat patients with resectable pancreatic cancer, which means the cancer can be surgically removed. Specifically, the trial is comparing two treatment...

Recruiting

Phase: PHASE3 Type: interventional Locations: Seoul, , Korea, Republic Of, Seoul, , Korea, Republic Of

Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer

NCT ID: NCT03492671

This clinical trial is exploring whether a combination of two chemotherapy drugs, gemcitabine and nab-paclitaxel, along with radiation therapy, can improve outcomes for patients with localized panc...

Recruiting

Phase: PHASE2 Type: interventional Locations: Loma Linda, California, United States

A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

NCT ID: NCT05624918

This clinical trial is investigating a new treatment approach for patients with resectable pancreatic adenocarcinoma, a type of pancreatic cancer that can be surgically removed. The study combines ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Columbus, Ohio, United States

Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab

NCT ID: NCT06172036

This clinical trial is studying a new treatment for patients with resectable pancreatic cancer, which means their tumors can potentially be removed through surgery. The treatment involves a combina...

Not yet recruiting

Phase: PHASE2 Type: interventional

Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer

NCT ID: NCT05788744

This clinical trial is exploring new ways to predict how well patients with localized pancreatic cancer might do after surgery. Specifically, researchers want to see if certain blood tests that che...

Recruiting

Phase: NA Type: interventional Locations: Odense, , Denmark, Aarhus, , Denmark +3 more

Phase II Study on Sequential AG and FOLFIRINOX as Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer

NCT ID: NCT05679050

This clinical trial is studying a new treatment approach for patients with resectable pancreatic cancer, which means the cancer can potentially be removed through surgery. The trial is looking at a...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tianjin, Tianjin, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions